Hypertrophic Cardiomyopathy (HCM) is a complex genetic heart condition characterized by thickened heart muscle, which can obstruct blood flow. Common symptoms include chest pain, shortness of breath, and fainting. The 2024 AHA/ACC guidelines have introduced updates: Mavacamten: A new treatment option for symptomatic obstructive HCM when first-line treatments fail. Physical Activity: Encouraging more inclusive physical activity for patients, challenging previous restrictions. #HCM #Cardiology #He

14 reactions | It’s difficult to experience unexplained symptoms and not know what they mean. For people with hypertrophic cardiomyopathy (HCM), it can be especially hard to pin down what is causing symptoms. Explore our interactive symptom guide to help discuss with your doctor. | Bristol Myers Squibb | Facebook

1.8K views · 27 reactions | Symptoms and testing done by her doctor led Lindsay Davis to a diagnosis of hypertrophic cardiomyopathy (HCM), a heart disease that affects an estimated ~700,000 people in the U.S., yet a majority remain undiagnosed. Listen to her story and join us in recognizing #HCMAwarenessDay on February 23. | Bristol Myers Squibb | Facebook